What laboratory tests should be ordered for the evaluation and management of Kawasaki disease in the emergency department?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Kawasaki Disease Evaluation in the Emergency Department

Order a complete blood count with differential, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), comprehensive metabolic panel including liver transaminases, albumin, and urinalysis as your initial laboratory workup for suspected Kawasaki disease in the ED 1.

Essential Initial Laboratory Panel

The American Heart Association guideline provides clear direction on which labs support the diagnosis of KD, particularly when clinical features are incomplete or atypical 1:

Core Inflammatory Markers

  • ESR and CRP: Nearly universal elevation in KD. Clinical experience suggests KD is unlikely if ESR, CRP, and platelet count are all normal after day 7 of illness 1. The ESR showed 95% abnormality rate in one cohort 2, making it highly sensitive though not specific.
  • Important caveat: ESR becomes elevated after IVIG therapy, so use CRP (not ESR) to assess treatment response 1.

Complete Blood Count

  • White blood cell count: Leukocytosis with granulocyte predominance is typical 1. WBC < 20 × 10⁹/L showed 80.9% sensitivity and 79.7% specificity for distinguishing KD from adenoviral infection 3.
  • Hemoglobin: Normochromic, normocytic anemia occurs in 83.3% of patients 2.
  • Platelet count: Thrombocytosis typically appears in the second week (peaking around 700,000/mm³ in week 3), but early thrombocytopenia is a red flag for disseminated intravascular coagulation and increased risk of coronary artery abnormalities 1.

Hepatic Function

  • AST/ALT and GGT: Elevated in 40-60% of patients 1. Higher transaminase levels help differentiate KD from infectious mimics 3.
  • Bilirubin: Mild hyperbilirubinemia in approximately 10% 1.
  • Albumin: Hypoalbuminemia is common and correlates with more severe, prolonged disease 1.

Urinalysis

  • Sterile pyuria: Present in up to 80% of children, though lacks specificity 1. Helps support the diagnosis when other features are present.

Key Diagnostic Pitfalls

Beware of leukopenia and lymphocyte predominance—these suggest an alternative diagnosis, not KD 1. This is critical for avoiding misdiagnosis in the ED.

The combination of normal ESR, CRP, and platelet count after day 7 makes KD highly unlikely, but remember that thrombocytosis may not appear until week 2-3 1. Don't rule out KD in the first week based on normal platelets alone.

Additional Testing for Specific Clinical Scenarios

If arthritis is present, arthrocentesis yields purulent-appearing fluid with WBC 125,000-300,000/mm³, normal glucose, and negative cultures 1.

For patients with severe neurological symptoms, lumbar puncture shows pleocytosis (30% of cases) with mononuclear predominance, normal glucose, and generally normal protein 1.

Algorithm for Laboratory Interpretation

  1. Day 1-7 of fever: Order CBC, ESR, CRP, CMP with LFTs, albumin, and UA
  2. If all inflammatory markers normal after day 7: Consider alternative diagnoses
  3. If WBC > 20 × 10⁹/L with low platelets early: Evaluate for DIC and higher CAA risk
  4. If transaminases elevated with hypoalbuminemia: Supports KD diagnosis, indicates more severe disease

The evidence consistently shows that no single biomarker is superior to ESR and CRP for supporting the diagnosis 1, so focus your laboratory workup on these core tests rather than pursuing novel biomarkers in the ED setting.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.